These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 23574541

  • 1. Safety evaluation of desloratadine in allergic rhinitis.
    González-Núñez V, Valero A, Mullol J.
    Expert Opin Drug Saf; 2013 May; 12(3):445-53. PubMed ID: 23574541
    [Abstract] [Full Text] [Related]

  • 2. The safety and efficacy of desloratadine for the management of allergic disease.
    Berger WE.
    Drug Saf; 2005 May; 28(12):1101-18. PubMed ID: 16329713
    [Abstract] [Full Text] [Related]

  • 3. Desloratadine treatment for intermittent and persistent allergic rhinitis: a review.
    Bachert C, van Cauwenberge P.
    Clin Ther; 2007 Sep; 29(9):1795-802. PubMed ID: 18035184
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis.
    Simons FE, Prenner BM, Finn A, Desloratadine Study Group.
    J Allergy Clin Immunol; 2003 Mar; 111(3):617-22. PubMed ID: 12642846
    [Abstract] [Full Text] [Related]

  • 5. Safety of desloratadine syrup in children.
    Bloom M, Staudinger H, Herron J.
    Curr Med Res Opin; 2004 Dec; 20(12):1959-65. PubMed ID: 15701213
    [Abstract] [Full Text] [Related]

  • 6. Assessing satisfaction with desloratadine and fexofenadine in allergy patients who report dissatisfaction with loratadine.
    Glass DJ, Harper AS.
    BMC Fam Pract; 2003 Aug 13; 4():10. PubMed ID: 12917016
    [Abstract] [Full Text] [Related]

  • 7. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
    Bachert C.
    Clin Ther; 2009 May 13; 31(5):921-44. PubMed ID: 19539095
    [Abstract] [Full Text] [Related]

  • 8. [Multicenter study of the effectiveness and tolerability of desloratadine in seasonal allergic rhinitis].
    Farkas H.
    Orv Hetil; 2003 May 25; 144(21):1021-4. PubMed ID: 12847854
    [Abstract] [Full Text] [Related]

  • 9. Desloratadine therapy for symptoms associated with perennial allergic rhinitis.
    Kim K, Sussman G, Hébert J, Lumry W, Lutsky B, Gates D.
    Ann Allergy Asthma Immunol; 2006 Mar 25; 96(3):460-5. PubMed ID: 16597081
    [Abstract] [Full Text] [Related]

  • 10. Safety and efficacy of desloratadine in subjects with seasonal allergic rhinitis or chronic urticaria: results of four postmarketing surveillance studies.
    Bachert C, Maurer M.
    Clin Drug Investig; 2010 Mar 25; 30(2):109-22. PubMed ID: 20067329
    [Abstract] [Full Text] [Related]

  • 11. Desloratadine for allergic rhinitis.
    See S.
    Am Fam Physician; 2003 Nov 15; 68(10):2015-6. PubMed ID: 14655812
    [No Abstract] [Full Text] [Related]

  • 12. Effect of desloratadine on the control of morning symptoms in patients with seasonal and perennial allergic rhinitis.
    Schenkel EJ.
    Allergy Asthma Proc; 2006 Nov 15; 27(6):465-72. PubMed ID: 17176780
    [Abstract] [Full Text] [Related]

  • 13. Adult and paediatric poor metabolisers of desloratadine: an assessment of pharmacokinetics and safety.
    Prenner B, Kim K, Gupta S, Khalilieh S, Kantesaria B, Manitpisitkul P, Lorber R, Wang Z, Lutsky B.
    Expert Opin Drug Saf; 2006 Mar 15; 5(2):211-23. PubMed ID: 16503743
    [Abstract] [Full Text] [Related]

  • 14. [Nasal obstruction on the decline. Antihistamine allows allergic patients to breathe].
    MMW Fortschr Med; 2004 Jul 08; 146(27-28):52. PubMed ID: 15526672
    [No Abstract] [Full Text] [Related]

  • 15. [Modern antihistaminics against allergic rhinitis. Better breathing without side effects].
    MMW Fortschr Med; 2003 Oct 30; 145(44):46. PubMed ID: 14655512
    [No Abstract] [Full Text] [Related]

  • 16. A comparison of the effect of diphenhydramine and desloratadine on vigilance and cognitive function during treatment of ragweed-induced allergic rhinitis.
    Wilken JA, Kane RL, Ellis AK, Rafeiro E, Briscoe MP, Sullivan CL, Day JH.
    Ann Allergy Asthma Immunol; 2003 Oct 30; 91(4):375-85. PubMed ID: 14582817
    [Abstract] [Full Text] [Related]

  • 17. Desloratadine and pseudoephedrine combination therapy as a comprehensive treatment for allergic rhinitis and nasal congestion.
    Anolik R.
    Expert Opin Drug Metab Toxicol; 2009 Jun 30; 5(6):683-94. PubMed ID: 19473112
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of desloratadine on conjunctival allergen challenge-induced ocular symptoms.
    Torkildsen GL, Gomes P, Welch D, Gopalan G, Srinivasan S.
    Clin Exp Allergy; 2009 Jul 30; 39(7):1052-9. PubMed ID: 19302250
    [Abstract] [Full Text] [Related]

  • 19. Evidence of desloratadine syrup efficacy and tolerability in children with pollen-induced allergic rhinitis.
    Rossi GA, Tosca MA, Passalacqua G, Bianchi B, Le Grazie C, Canonica GW.
    Allergy; 2005 Mar 30; 60(3):416-7. PubMed ID: 15679739
    [No Abstract] [Full Text] [Related]

  • 20. Desloratadine: an update of its efficacy in the management of allergic disorders.
    Murdoch D, Goa KL, Keam SJ.
    Drugs; 2003 Mar 30; 63(19):2051-77. PubMed ID: 12962522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.